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SUMMARY 
The chromosomal translocation associated with many tumors of immunoglobulin-producing cells frequently 
results in the joining of the immunoglobulin heavy-chain locus and the c-myc oncogene. This translocation of 
c-myc has profound structural and functional consequences for the oncogene, including loss of the 5’ end of 
the gene and transcriptional deregulation. We report in this communication that translocation results in a new 
methylation pattern of c-myc. In normal kidney and liver tissue, the c-myc gene is methylated at its 3’ end. The 
translocated gene in plasmacytoma DNA is extensively demethylated. On the other hand, the nonrearranged 
c-myc gene in plasmacytoma DNA (which is transcriptionally silent) is extensively methylated. In addition, we 
confirm the nucleotide sequence (with 19 discrepancies out of 1400 bp) 5’ to the murine c-myc gene, as reported 
by Corcoran et al. [Cell 40 (1985) 71-791. 
INTRODUCTION 
The characteristic chromosomal translocation 
found in many B cell tumors results in the joining of 
a c-myc oncogene (from murine chromosome 15) to 
the immunoglobulin heavy-chain locus (chromo- 
some 12: Klein, 1983; Perry, 1983; Robertson, 
1983). As a result of the reciprocal translocation 
process, the 5’ end of the c-myc gene is separated 
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Abbreviations: bp, base pair(s); kb, 1000 bp; NIARD, see Fig. 2 
and section c; SDS, sodium dodecyl sulfate; SSC, 0.15 M NaCI, 
0.015 M Na, . citrate, pH 7-8. 
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from the bulk of the gene. DNA from plasmacytoma 
cells have parts of the c-myc gene in three different 
locations: a nonrearranged version of the gene on a 
normal chromosome 15 ; the bulk of the gene, includ- 
ing all of the protein-coding potential, associated 
with the part of immunoglobulin heavy-chain locus 
on a 12: 15 translocation chromosome; and the 5’ 
end of the c-myc gene associated with the 5’ end of 
the heavy-chain locus on a 15 : 12 translocated chro- 
mosome (Cory et al., 1983). Translocation and trun- 
cation of c-myc are correlated with increased tran- 
scriptional activity of the translocated gene, but 
transcriptional silence of the normal c-myc gene 
(Perry, 1983; Robertson, 1983). 
Eukaryotic genes that are transcriptionally active 
tend to be undermethylated, whereas those that are 
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transcriptionally less active tend to be methylated 
(Razin and Riggs, 1980). Prevention of methylation 
by 5azacytidine results in dramatic increases in 
transcriptional activity of some eukaryotic genes 
(Groudine et al., 1981; Compere and Palmiter, 
198 1). Finally, recombinant DNA molecules propa- 
gated in Escherichia coli, and therefore carrying all of 
their CpG dinucleotides in the demethylated form, 
are transcriptionally active when inserted into 
eukaryotic nuclei. On the other hand, the same 
recombinant DNA molecules, when methylated in 
vitro, are now inactive in eukaryotic nuclei (Fradin 
et al., 1982; Busslinger et al., 1983). We have studied 
the effect of c-myc translocation on gene structure by 
investigation of the methylation pattern of the c-myc 
gene from plasmacytoma cells and from normal 
(kidney and liver) cells. 
EXPERIMENTAL AND DISCUSSION 
(a) Clones and methods 
The recombinant DNA molecule yM52 includes 
the translocated c-myc gene from the murine plasma- 
cytoma P3. The recombinant DNA molecule pX27-3 
includes the reciprocal product of the P3 trans- 
location; that is, half of the first exon, and all of the 
5’-flanking region. The derivation and structure of 
these clones have been described in detail elsewhere 
(Dunnick et al., 1983). The clone LFll is a Hind111 
subclone in Ml3 of a 1.5-kb Hind111 fragment that 
includes a large portion of 5’-flanking sequences of 
the murine c-myc gene from the clone pX27-3, and 
ends at the Hind111 site in the 5’-most exon (Fig. 1). 
Methods for determining nucleotide sequences 
and for Southern hybridization analysis are de- 
scribed in the appropriate figure legends. 
(b) Sequence of c-myc 5’ flanking region 
The sequence of 1400 bp of murine c-myc 5’ 
flanking region was determined. As this sequence 
has been published by Corcoran et al. (1985), we 
present here only the 19 discrepancies (see legend to 
Fig. 1). This sequence will serve as a database for at 
least two different lines of investigation. (i) It will aid 
in the exact location of c-myc translocation sites in 
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Fig. 1. Sequences in the murine c-m.rc oncogene. A schematic 
diagram of the 5’-flanking region and part of the first exon 
(darkened box) of the translocated c-myc gene in the murine 
plasmacytoma P3 is shown. The direction and extent of dideoxy 
sequences (Sanger et al., 1980), derived in bacteriophage Ml3 
(Messing and Vieira, 1982) from HindHI, Sau3A or HpaII 
restriction fragments, or from random fragments generated by 
sonications are shown. Our sequence is exactly the same as that 
derived from the germline c-myc gene by Corcoran et al. (1985), 
with the following discrepancies (numbering according to Cor- 
coran et al., 1985): delete T-1392; delete G-897; insert G after 
-890; insert G after -761; delete G-746; substitute G for C-745; 
delete G-743; delete T-536; delete C-405; delete A-357; insert C 
after -266; substitute G for A-190; insert G after -183; insert C 
after -141; substitute G for A-109; delete A-100; insert two As 
after -95; substitute A for G-60; delete G-12. 
the 5’ end of the gene and the analysis of nucleotide 
sequences that might be important to the trans- 
location process. (ii) It provides the sequence of the 
5’ end of the gene, a region that may play a key role 
in gene regulation (Perry, 1983; Robertson, 1983). 
(c) Methylation of CCGG sites 
We found a high concentration of HpaII sites 
(recognition sequence CCGG) in the 5’-flanking 
region of this gene. Because the 5’ end of the c-myc 
gene may be important to regulation of gene expres- 
sion, and because it includes so many CCGG se- 
quences, we were interested to determine the extent 
and pattern of methylation of c-myc genes with 
different structures in different tissues. Using HpaII 
cleavage, and the Southern (1975) hybridization 
technique, we examined the methylation state of 
c-myc in a mixture of kidney and liver DNA, and in 
P3 (a murine plasmacytoma cell line) DNA (Fig. 2). 
Of course, neither allele is rearranged in kidney and 
liver DNA; both c-myc genes are found in a 9.8-kb 
KpnI fragment (lane 5). With the probe for the 
second exon, third exon, first intron, and second 
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Fig. 2. Methylation of the c-myc oncogene. (a) High-M, DNA 
from pooled kidneys and livers (lanes 2, 4, 5, and 7) or from 
plasmacytoma P3 (lanes 1, 3, 6, and 8) was digested with KpnI 
alone (lanes 3-6) or with KpnI + HpaII (lanes 1,2,7, and 8). The 
digested samples were fractionated on a 0.8% agarose gel and 
blotted onto nitrocellulose paper (Southern, 1975). Hybrid- 
ization to nick-translated 5’-flanking region probe (LFl 1) (lanes 
l-4) or the probe for the second exon, third exon, first intron, 
and second intron (NIARD; Harris et al., 1982; lanes 5-8) was 
in 6 x SSC at 68°C. The sizes (in kb) of some DNA fragments 
are shown. (b)A restriction enzyme cleavage site map (with 
relevant sites only) for the murine c-myc gene. Vertical lines 
below the gene: known HpaII sites. HpaII sites in the 3’ end of 
the c-myc gene were determined by mapping of the c-myc 
molecular clone yM52 (Dunnick et al., 1983). Black boxes: c-myc 
exons. The arrow above the first c-myc exon notes the trans- 
location site in P3 DNA (Neuberger and Cabali, 1983; Dunnick 
et al., 1983). We have digested plasmacytoma P3 DNA and a 
mixture of murine kidney and liver DNA with KpnI (K) alone, 
with EcoRI (E) alone, with Hind111 (H) alone, or with 
BumHI +XbaI (BX). After the primary digestion, each sample 
was digested with HpaII and subjected to Southern hybrid- 
ization analysis. Some of the resulting autoradiographs are 
shown in Fig. 2a and 3b,c. Analysis of that set of data (including 
those not shown) allowed us to locate the various restriction 
fragments within the c-myc gene. The size and location of those 
fragments is shown. The enzyme used in the primary digestion, 
intron of c-myc (NIARD; Harris et al., 1982), we 
detected both the germline and translocated alleles 
(9.8- and 7.6-kb fragments; lane 6) in P3 DNA. (The 
greater hybridization signal associated with the 
translocated fragment is likely to reflect ploidy differ- 
ences between the translocated and normal chromo- 
somes.) KpnI + HpaII digestion of kidney and liver 
DNA, followed by Southern hybridization analysis 
with the NIARD probe, revealed three predominant 
fragments (0.7, 3.5 and 4.2-kb, lane 7). Primary 
digestion with EcoRI, BamHI +XbaI, or Hind111 
instead of KpnI allowed us to place these fragments 
at the 3’ end of the c-myc gene, suggesting complete 
methylation of the HpaII site in the second intron, 
and partial methylation of the site in the second 
exon. Similar experiments with plasmacytoma P3 
DNA revealed a different pattern of methylation. In 
P3 DNA at least one allele is extensively under- 
methylated, yielding 2.6, 1.0, and 0.7-kb fragments 
(lane 8). On the other hand, fragments equal to or 
larger than those observed in kidney and liver DNA 
were also detected (3.5, 6.2, and 7.6 kb). 
(d) Differential methylation of two plasmacytoma 
c-myc alleles 
To determine which allele in P3 DNA is methyl- 
ated and which is demethylated, we fractionated the 
two alleles by centrifugation in a sucrose gradient. 
The normal allele is found in a 20-kb EcoRI fragment 
(Harris et al., 1982; Cory et al., 1983) whereas the 
translocated allele is found in a 14-kb fragment (Cory 
et al., 1983; Dunnick et al., 1983). EcoRI-digested 
P3 genomic DNA was fractionated on a sucrose 
gradient, and fractions were pooled as described in 
Fig. 3a. These fractionated DNA samples were fur- 
with HpaII being used in every case in the secondary digestion, 
is indicated by the appropriate abbreviation. For example, the 
3.5-kb fragment resulting from primary digestion with KpnI and 
secondary digestion with HpuII, and detected by the NIARD 
probe [lane 7, in (a)], is located in the second exon, second 
intron, and third exon of the kidney and liver gene. In those cases 
in which two or three enzymes are indicated, the same fragment 
resulted from digestion with any of the indicated enzymes and 
HpuII. The broken lines for the normal P3 gene denote partial 
methylation of the HpuII sites at the 5’ end of this gene. In P3 
DNA, fragments were assigned to the normal or translocated 





Fig. 3. Methylation of c-myc in plasmacytoma P3 DNA. 
(a) High-M, DNA from P3 cells was digested with EcoRI and 
fractionated on a sucrose gradient. Fractions 15 to 27 were 
concentrated by ethanol precipitation, and aliquots were frac- 
tionated on an agarose gel. The DNA samples in the gel were 
blotted onto nitrocellulose by the Southern (1975) procedure and 
hybridized to radiolabeled c-myc NIARD probe. Fractions 15 to 
18, containing the nonrearranged c-myc gene in a 20-kb EcoRI 
fragment, were pooled. Fractions 24 to 26, containing the trans- 
located c-myc gene in a 14-kb EcoRI fragment, were also pooled. 
(b) DNA samples of P3 DNA (lane 1), fractions 24 to 26 (lane 
2), or fractions 15 to 18 (lane 3) were digested with HindIII, 
fractionated on an agarose gel, blotted onto nitrocellulose paper, 
and hybridized to the radiolabeled NIARD (see Fig. 2) probe. 
(c) DNA samples of P3 DNA (lanes 4 and 5), of sucrose gradient 
fractions 24 to 26 (T, lane 6), of sucrose gradient fractions 15 to 
18 (N, lane 7), or of kidney and liver DNA (lanes 8 and 9) were 
digested with Hind111 (lanes 4 and 9) or Hind111 + HpaII (lanes 
5, 6, 7, and 8). The digested samples were then fractionated on 
a 1.1% agarose gel, blotted onto nitrocellulose paper, and 
hybridized with the NIARD probe in 6 x SSC at 68°C. Sizes of 
fragments in kb are indicated on the left-hand margin of the 
autoradiographs. 
ther digested with Hind111 (Fig. 3b). The fraction 
including the translocated allele contained a large 
amount of the 6.0-kb Hind111 fragment associated 
with the translocated gene, and a small amount of the 
4.5-kb fragment associated with the normal gene 
(Fig. 3b, lane 2). The fraction including the normal 
allele was a mixture of about equal amounts of the 
6.0-kb translocated fragment and 4.5-kb normal 
fragment (Fig. 3b, lane 3). 
These P3 DNA fractions, along with genomic 
DNA from P3 plasmacytoma DNA and a mixture of 
kidney and liver DNA, were digested with Hind111 
and H&I and analyzed by the Southern hybrid- 
ization procedure (Fig. 3~). The c-myc genes in 
kidney and liver DNA are found in a (non- 
rearranged) 4.5-kb Hind111 fragment (lane 9) and are 
methylated to an intermediate extent (lane 8). The 
c-myc genes in plasmacytoma P3 DNA seem to fall 
into two sets: one is extensively demethylated, the 
other extensively methylated (lane 5). The trans- 
located allele appears to be the demethylated c-myc 
gene, as the fraction including this allele yielded the 
small fragments associated with extensive demethyl- 
ation of the gene (Fig. 3c, lane 6). On the other hand, 
the fraction which included both alleles yielded 4.5- 
and 4.0-kb HindIII-HpaII fragments (lane 7). These 
larger fragments indicate that the normal allele is 
extensively methylated, HpaII cutting the Hind111 
fragment once or not at all. This fraction also yielded 
a small amount of the 0.7-l.O-kb fragments associ- 
ated with demethylation. The intensity of hybrid- 
ization of these small fragments is consistent with the 
level of contamination by the translocated allele. The 
hybridization signal of the small fragments (lane 7) is 
much reduced compared to either the purified trans- 
located fragment (lane 6) or the total genomic DNA 
(lane 5), even though the hybridization signal of the 
4.0 and 4.5-kb fragments is much greater than that 
for the translocated allele (lane 6) and equal to that 
for the total plasmacytoma DNA (lane 5). P3 DNA, 
and DNA from both fractions, yields a 2.0-kb 
HindIII-&a11 fragment. From the relative intensity 
of hybridization of this fragment in the various lanes, 
it appears that the translocated allele is partially 
methylated at the HpuII site in the second intron, 
resulting in a 2.0-kb fragment. Nevertheless, it is also 
possible that some of this fragment is derived from 
the population of normal c-myc genes. 
At least two HpuII sites at the 5’ end of the c-myc 
genes in kidney and liver DNA, and in P3 DNA, 
appeared to be undermethylated. With a 5’-flanking 
region probe, we detected a small (0.6-kb) fragment 
after &a11 digestion of either P3 or kidney and liver 
DNA (Fig. 2, lanes 1 and 2). After digestion with 
KpnIt only, this same probe detected the non- 
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rearranged c-myc gene in kidney and liver DNA (lane 
4), the nonrearranged gene in P3 DNA (lane 3, 
9.8-kb), and the translocated reciprocal product in 
P3 DNA (lane 3, 11 kb). From our limited analysis, 
we detected hypomethylation of some sites in the 5’ 
flanking region of the c-myc gene, but could not 
distinguish between translocated and normal c-myc 
genes. 
(e) Conclusions 
We have defined three different patterns of methyl- 
ation for murine c-myc genes. (i) The translocated 
c-myc gene in plasmacytoma DNA is largely 
demethylated and is transcriptionally active. It has 
been previously shown that the adjoining immuno- 
globulin gene is also demethylated (Dean et al., 
1983). (ii) The nonrearranged gene in plasmacytoma 
DNA is extensively methylated. In most plasma- 
cytomas, this normal allele is transcriptionally silent 
(Stanton et al., 1983; Adams et al., 1983). (iii) The 
c-myc genes in a mixture of kidney and liver DNA 
are methylated to an intermediate extent; that 
methylation takes place in the second exon and 
intron. The transcriptional activity of these normal 
kidney and liver genes might be very low. Never- 
theless, at least in liver DNA, the genes are capable 
of induction to very high rates of transcription 
(Makino et al., 1984). 
Genes that encode ‘housekeeping functions’ tend 
to be undermethylated in their promoter regions, but 
methylated at their 3’ ends (Stein et al., 1983). The 
kidney and liver c-myc gene seems to be methylated 
at its 3’ end (Figs. 2 and 3). Our limited analysis 
suggests undermethylation of the promoter region of 
the c-myc gene, but more extensive analysis will be 
necessary to confirm this point. 
The murine c-myc gene has more CpG dinucle- 
otides in its 5’ end than in its 3’ end (CpG dinucle- 
otides are slightly underrepresented in the second 
and third exons; Stanton et al., 1983; Bernard et al., 
1983). Even though the sequence of the second 
intron is not available, the presence of a single HpaII 
site in this intron suggests few CpG dinucleotides. 
Thus, c-myc seems to fit the observation of Tyko- 
cinski and Max (1984) that eukaryotic genes tend to 
have many CpG dinucleotides at their 5’ ends, but 
few at their 3’ ends. Tykocinski and Max also 
suggested that CpG dinucleotides are in low abun- 
dance in the 3’ end of eukaryotic genes because, in 
their methylated state, CpG dinucleotides tend to 
mutate to CpA or TpG. The methylation pattern and 
the CpG content of the 5’ and 3’ ends of the c-myc 
gene in kidney and liver DNA are consistent with 
this hypothesis. 
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